Investment Summary |
|
|---|---|
| Date | 2012-10-01 |
| Target | Emme |
| Sector | Electrical Equipment |
| Investor(s) | Advantage Capital Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Agnostic |
Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.
| DEAL STATS | # |
|---|---|
| Overall | 139 of 329 |
| Sector: Electrical Equipment M&A | 3 of 6 |
| Type: Venture M&A Deals | 80 of 125 |
| State: Connecticut M&A | 13 of 23 |
| Country: United States M&A | 139 of 325 |
| Year: 2012 M&A | 14 of 18 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-19 |
Pasteuria Bioscience
Alachua, Florida, United States Pasteuria Bioscience, Inc. is involved in commercializing a biological solution to nematode control, a unmet agricultural pest problem. The company has producing an in-vitro form of a pathological parasite for particular species of harmful nematodes. The company is currently focused on scaling up the in-vitro production process to commercial levels. |
Sell | $86M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-22 |
Cleveland HeartLab
Cleveland, Ohio, United States Cleveland HeartLab, Inc. is a diagnostics company specializing in the detection, prevention, and management of cardiovascular disease from a proprietary product pipeline licensed exclusively from the Cleveland Clinic, the global leader in cardiac health. |
Buy | - |
